Evidence map›Paper›PMID 26015264›Full record

ArticleJournal of cellular biochemistry2015

Insulin-Like Growth Factor II (IGF-II) Inhibits IL-1β-Induced Cartilage Matrix Loss and Promotes Cartilage Integrity in Experimental Osteoarthritis.

Tomoya Uchimura, Andrea T Foote, Eric L Smith, Elizabeth G Matzkin, Li Zeng

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular biochemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. IGF/IGF-1R signal pathway in pain: a promising therapeutic target.International journal of biological sciences · 2023
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Effects of Sprifermin, IGF1, IGF2, BMP7, or CNP on Bovine Chondrocytes in Monolayer and 3D Culture.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2020
    Article
  14. Review
  15. Article
  16. [Research progress on signaling molecules involved in articular cartilage repair].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2019
    Review
  17. Article
  18. Article
  19. MicroRNAs in orthopaedic research: Disease associations, potential therapeutic applications, and perspectives.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Tomoya UchimuraProgram in Cellular, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts, 02111.
Andrea T FooteDepartment of Integrative Physiology and Pathobiology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts, 02111.
Eric L SmithDepartment of Orthopaedic Surgery, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts, 02111.
Elizabeth G MatzkinDepartment of Orthopaedic Surgery, Tufts Medical Center, 800 Washington Street, Boston, Massachusetts, 02111.
Li ZengProgram in Cellular, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, 136 Harrison Avenue, Boston, Massachusetts, 02111.
Tufts University · USTufts Medical Center · US

Funding

Tufts Clinical and Translational Research InstituteUL1TR001064 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2013 to 2017
$26.4M
Muscle Cell-Enhanced Cartilage Tissue EngineeringR01AR059106 · NIAMS · TUFTS UNIVERSITY BOSTON · PI ZENG, LI · 2010 to 2014
$1.8M
Nkx3.2 nuclear localization and cartlidge formationR03AR054611 · NIAMS · TUFTS UNIVERSITY BOSTON · PI ZENG, LI · 2007 to 2009
$242k
NCATS NIH HHS UL1 TR001064NCATS NIH HHS UL1TR001064NIAMS NIH HHS 1R01 AR059106-01A1NIAMS NIH HHS AR054611NIAMS NIH HHS R01 AR059106NIAMS NIH HHS R03 AR054611
6 · The paper itself

Abstract

Osteoarthritis (OA) is a widespread chronic joint disease characterized by articular cartilage destruction and accompanied by pain and disability. In this study, we found that the expression of Insulin-like Growth Factor II (IGF-II) was reduced in articular cartilage in human OA patients as well as in the murine experimental OA model of destabilization of the medial meniscus (DMM). In primary human articular chondrocytes, ectopic expression of lentiviral IGF-II inhibited pro-inflammatory cytokine IL-1β-induced NF-κB activation as well as catabolic gene expression. Interestingly, IGF-II did not significantly alter the phosphorylation states of ERK1/2 or Akt, which are kinases typically activated by IGF-I. Instead, it induced the activity of phospholipase C (PLC) and a PLC inhibitor blocked the inhibitory activity of IGF-II against IL-1β, suggesting that this activity is mediated through PLC. Furthermore, IGF-II increased cartilage matrix levels and decreased MMP13 protein expression in explanted human OA cartilage cultures in vitro. In the in vivo DMM model, intraarticular injection of lentiviral IGF-II led to enhanced cartilage matrix levels and decreased MMP13 protein expression, as well as reduced osteophyte formation and subchondral bone sclerosis. Therefore, our results suggest that IGF-II can promote cartilage integrity and halt knee joint destruction in OA.

Indexed as

AnimalsArthritis, ExperimentalCartilage, ArticularChondrocytesGene Expression RegulationHumansInsulin-Like Growth Factor IIInterleukin-1betaMatrix Metalloproteinase 13Menisci, TibialMiceNF-kappa BOsteoarthritisSignal TransductionIGF2 protein, humanInsulin-Like Growth Factor IIInterleukin-1betaMatrix Metalloproteinase 13Mmp13 protein, mouseNF-kappa BCARTILAGEDMMIGF-IIIL-1βKNEE JOINTNF-κBOSTEOARTHRITIS (OA)

Identifiers

PMID26015264
PMCPMC5630262
OpenAlexW2105445101

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.